Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
about
Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platformProgress and Prospect: A Bibliometric Analysis of Research Papers by Korean Allergists Over Recent Five Years (2009-2013)Rituximab Desensitization in Pediatric Patients: Results of a Case SeriesPractical Management of Patients with a History of Immediate Hypersensitivity to Common non-Beta-Lactam Drugs.AllergoOncology - the impact of allergy in oncology: EAACI position paper.Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.Methotrexate hypersensitivity reactions in pediatrics: Evaluation and management.
P2860
Q28596492-85BFD194-9F09-463F-9A58-1FFB7A7E50F5Q35872148-0E87A89E-D6DB-43E6-BD5E-2448EEAA8D7CQ37050013-1CF9C577-7AE1-4A0F-8730-9C0356A0F979Q38682358-FF604185-40E5-4D90-B493-AA9C762D6496Q38776716-B6C8F2D4-B7F9-4B9B-B87F-17712AF39B59Q41127404-419B750F-908C-4C6D-9489-33D75EDF0D31Q54839689-D804101D-02B0-45F2-9EF4-CFC542C2AEB8
P2860
Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
@en
type
label
Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
@en
prefLabel
Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
@en
P2860
P1476
Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
@en
P2093
Karen S Hsu Blatman
Mariana C Castells
P2860
P2888
P356
10.1007/S11882-014-0453-5
P577
2014-08-01T00:00:00Z
P6179
1005504503